BOOTH #1909
Looking for a way to improve the limit of detection for low-frequency CNVs and mutations?
Explore NuProbe’s Oncology Research Technologies at AACR – Proprietary technologies to enable ultrasensitive detection while overcoming the challenges of current methods.
EXHIBITOR SPOTLIGHT THEATER PRESENTATION
A Novel Approach to Ultrasensitive Detection and Quantification of Copy Number Variations and Mutations
MONDAY, APRIL 11, 2022 | 10 AM | THEATER B, EXHIBIT HALL, ERNEST N. MORIAL CONVENTION CENTER
In this talk, we will introduce Quantitative Amplicon Sequencing (QASeq): a highly sensitive method for the ultrasensitive detection and quantification of somatic Copy Number Variations (CNVs) and mutations from tissue and liquid biopsy samples. Using a PCR-based molecular barcoding NGS approach with high multiplexing, QASeq enables accurate absolute quantitation of CNVs down to 5% heterozygous single copy gain or loss (ploidy=2.05/1.95). Additionally, we will introduce NuProbe’s custom assay development and validation solutions for oncology research applications.
Register Now
Speaker
Nicolas Garreau de Loubresse, Ph.D.
DIRECTOR OF BUSINESS DEVELOPMENT
Nicolas Garreau de Loubresse, Ph.D., serves as Director of Business Development for NuProbe, USA. Previously, he was a Research Fellow at the Wyss Institute at Harvard University and a Business Development Fellow at Harvard Office of Technology Development. He is also the co-founder of Urania Therapeutics and inventor of Urania’s core technologies. He published first-author articles in Science and Nature, and received competitive fellowships (EMBO, HFSP) and awards (AXA-French Academy of Science).
POSTER #17 ABSTRACT #2806
High Sensitivity qPCR Microsatellite Instability Detection in FFPE Tissue
EXHIBIT HALLS D-H, POSTER SECTION 32
Blake Young, M.S.
RESEARCHER
Blake is a core member of the research and development team at NuProbe responsible for developing MSI detection using blocker displacement amplification technology and qPCR. His responsibilities include assay design and optimization, troubleshooting, and creating and running experimental plans. Blake‘s primary area of focus is qPCR-based assays. Blake has a Master of Science in Forensic Science from Sam Houston State University. Prior to joining NuProbe, he worked on forensic DNA analysis at Harris County Institute of Forensic Sciences.
